The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Women Health Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
The global Women Health Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Women Health Diagnostics in various end use industries. The expanding demands from the Diagnostic and imaging centers, Hospitals and clinics and Home care,, are propelling Women Health Diagnostics market. Breast cancer testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cervical cancer testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Women Health Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Women Health Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Women Health Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Women Health Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Women Health Diagnostics covered in this report include Quest Diagnostics, Abbott, BD, Roche, GE Healthcare, Biomerieux, Philips, DIALAB and Fujifilm, etc.
The global Women Health Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Quest Diagnostics
Abbott
BD
Roche
GE Healthcare
Biomerieux
Philips
DIALAB
Fujifilm
GenMark
Hologic
Luminex
Nova Biomedical
PerkinElmer
Siemens Healthineers
Global Women Health Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Women Health Diagnostics market, Segment by Type:
Breast cancer testing
Cervical cancer testing
Osteoporosis testing
Pregnancy & fertility testing
Ovarian cancer testing
Infectious disease testing
Prenatal genetic screening and carrier testing
Ultrasound tests
HIV testing
Global Women Health Diagnostics market, by Application
Diagnostic and imaging centers
Hospitals and clinics
Home care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Women Health Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Women Health Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Women Health Diagnostics in various end use industries. The expanding demands from the Diagnostic and imaging centers, Hospitals and clinics and Home care,, are propelling Women Health Diagnostics market. Breast cancer testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cervical cancer testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Women Health Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Women Health Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Women Health Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Women Health Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Women Health Diagnostics covered in this report include Quest Diagnostics, Abbott, BD, Roche, GE Healthcare, Biomerieux, Philips, DIALAB and Fujifilm, etc.
The global Women Health Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Quest Diagnostics
Abbott
BD
Roche
GE Healthcare
Biomerieux
Philips
DIALAB
Fujifilm
GenMark
Hologic
Luminex
Nova Biomedical
PerkinElmer
Siemens Healthineers
Global Women Health Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Women Health Diagnostics market, Segment by Type:
Breast cancer testing
Cervical cancer testing
Osteoporosis testing
Pregnancy & fertility testing
Ovarian cancer testing
Infectious disease testing
Prenatal genetic screening and carrier testing
Ultrasound tests
HIV testing
Global Women Health Diagnostics market, by Application
Diagnostic and imaging centers
Hospitals and clinics
Home care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Women Health Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Women Health Diagnostics
1.1 Women Health Diagnostics Market Overview
1.1.1 Women Health Diagnostics Product Scope
1.1.2 Women Health Diagnostics Market Status and Outlook
1.2 Global Women Health Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Women Health Diagnostics Market Size by Region (2018-2029)
1.4 Global Women Health Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Women Health Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Women Health Diagnostics Market Size (2018-2029)
1.6.1 North America Women Health Diagnostics Market Size (2018-2029)
1.6.2 Europe Women Health Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Women Health Diagnostics Market Size (2018-2029)
1.6.4 Latin America Women Health Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Women Health Diagnostics Market Size (2018-2029)
2 Women Health Diagnostics Market by Type
2.1 Introduction
2.1.1 Breast cancer testing
2.1.2 Cervical cancer testing
2.1.3 Osteoporosis testing
2.1.4 Pregnancy & fertility testing
2.1.5 Ovarian cancer testing
2.1.6 Infectious disease testing
2.1.7 Prenatal genetic screening and carrier testing
2.1.8 Ultrasound tests
2.1.9 HIV testing
2.2 Global Women Health Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Women Health Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Women Health Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Women Health Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Women Health Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Women Health Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Women Health Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Women Health Diagnostics Revenue Breakdown by Type (2018-2029)
3 Women Health Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic and imaging centers
3.1.2 Hospitals and clinics
3.1.3 Home care
3.2 Global Women Health Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Women Health Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Women Health Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Women Health Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Women Health Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Women Health Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Women Health Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Women Health Diagnostics Revenue Breakdown by Application (2018-2029)
4 Women Health Diagnostics Competition Analysis by Players
4.1 Global Women Health Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Women Health Diagnostics as of 2022)
4.3 Date of Key Players Enter into Women Health Diagnostics Market
4.4 Global Top Players Women Health Diagnostics Headquarters and Area Served
4.5 Key Players Women Health Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Women Health Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Quest Diagnostics
5.1.1 Quest Diagnostics Profile
5.1.2 Quest Diagnostics Main Business
5.1.3 Quest Diagnostics Women Health Diagnostics Products, Services and Solutions
5.1.4 Quest Diagnostics Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Quest Diagnostics Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Women Health Diagnostics Products, Services and Solutions
5.2.4 Abbott Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 BD
5.3.1 BD Profile
5.3.2 BD Main Business
5.3.3 BD Women Health Diagnostics Products, Services and Solutions
5.3.4 BD Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Women Health Diagnostics Products, Services and Solutions
5.4.4 Roche Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 GE Healthcare
5.5.1 GE Healthcare Profile
5.5.2 GE Healthcare Main Business
5.5.3 GE Healthcare Women Health Diagnostics Products, Services and Solutions
5.5.4 GE Healthcare Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 GE Healthcare Recent Developments
5.6 Biomerieux
5.6.1 Biomerieux Profile
5.6.2 Biomerieux Main Business
5.6.3 Biomerieux Women Health Diagnostics Products, Services and Solutions
5.6.4 Biomerieux Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Biomerieux Recent Developments
5.7 Philips
5.7.1 Philips Profile
5.7.2 Philips Main Business
5.7.3 Philips Women Health Diagnostics Products, Services and Solutions
5.7.4 Philips Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Philips Recent Developments
5.8 DIALAB
5.8.1 DIALAB Profile
5.8.2 DIALAB Main Business
5.8.3 DIALAB Women Health Diagnostics Products, Services and Solutions
5.8.4 DIALAB Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 DIALAB Recent Developments
5.9 Fujifilm
5.9.1 Fujifilm Profile
5.9.2 Fujifilm Main Business
5.9.3 Fujifilm Women Health Diagnostics Products, Services and Solutions
5.9.4 Fujifilm Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Fujifilm Recent Developments
5.10 GenMark
5.10.1 GenMark Profile
5.10.2 GenMark Main Business
5.10.3 GenMark Women Health Diagnostics Products, Services and Solutions
5.10.4 GenMark Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 GenMark Recent Developments
5.11 Hologic
5.11.1 Hologic Profile
5.11.2 Hologic Main Business
5.11.3 Hologic Women Health Diagnostics Products, Services and Solutions
5.11.4 Hologic Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Hologic Recent Developments
5.12 Luminex
5.12.1 Luminex Profile
5.12.2 Luminex Main Business
5.12.3 Luminex Women Health Diagnostics Products, Services and Solutions
5.12.4 Luminex Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Luminex Recent Developments
5.13 Nova Biomedical
5.13.1 Nova Biomedical Profile
5.13.2 Nova Biomedical Main Business
5.13.3 Nova Biomedical Women Health Diagnostics Products, Services and Solutions
5.13.4 Nova Biomedical Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Nova Biomedical Recent Developments
5.14 PerkinElmer
5.14.1 PerkinElmer Profile
5.14.2 PerkinElmer Main Business
5.14.3 PerkinElmer Women Health Diagnostics Products, Services and Solutions
5.14.4 PerkinElmer Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 PerkinElmer Recent Developments
5.15 Siemens Healthineers
5.15.1 Siemens Healthineers Profile
5.15.2 Siemens Healthineers Main Business
5.15.3 Siemens Healthineers Women Health Diagnostics Products, Services and Solutions
5.15.4 Siemens Healthineers Women Health Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Siemens Healthineers Recent Developments
6 North America
6.1 North America Women Health Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Women Health Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Women Health Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Women Health Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Women Health Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Women Health Diagnostics Market Dynamics
11.1 Women Health Diagnostics Industry Trends
11.2 Women Health Diagnostics Market Drivers
11.3 Women Health Diagnostics Market Challenges
11.4 Women Health Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
